Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating radiation enteritis and preparation method and application of medicine

A radiation enteritis and drug technology, applied in the field of medicine, achieves the effect of simple preparation process, unique formula and low cost

Inactive Publication Date: 2017-03-22
郑州莉迪亚医药科技有限公司
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no effective treatment drug or method. Most of the medical institutions use symptomatic treatment, and the drugs used are also different. Most of them use western medicine for symptomatic treatment, such as giving anti-inflammatory and pain relief, rehydration and antidiarrheal, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 3 parts of levamisole, 11 parts of bromhexine, 5 parts of taurine, and 1 part of calcium pyruvate.

[0019] Mix levamisole, bromhexine, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 75°C, and stir at this temperature for 38 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

Embodiment 2

[0021] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 7 parts of levamisole, 19 parts of bromhexine, 13 parts of taurine, and 5 parts of calcium pyruvate.

[0022] Mix levamisole, bromhexine, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 77°C, and stir at this temperature for 40 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

Embodiment 3

[0024] In an embodiment of the present invention, a medicine for treating radiation enteritis is composed of the following raw materials in parts by weight: 4 parts of levamisole, 13 parts of bromhexine, 7 parts of taurine, and 2 parts of calcium pyruvate.

[0025] Mix levamisole, bromhexine, and calcium pyruvate, add 3.1 times the mass of deionized water, raise the temperature to 76°C, and stir at this temperature for 39 minutes to prepare mixture A. The mixture A was mixed with taurine, subjected to ultrasonic treatment at 58° C. for 25 minutes with an ultrasonic power of 900 W, and then stirred at 63° C. until dry to obtain the drug.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating radiation enteritis and a preparation method and application of the medicine. The medicine is composed of the following raw materials including, by weight, 3-7 parts of levamisole, 11-19 parts of bromhexine, 5-13 parts of taurine and 1-5 parts of calcium pyruvate. The levamisole, the bromhexine and the calcium pyruvate are mixed and added into deionized water, and the mixture is heated to 75 DEG C to 77 DEG C and stirred for 38 min to 40 min to prepare the mixture A; the mixture A and the taurine are mixed and subjected to ultrasonic treatment at 58 DEG C for 25 min, the ultrasonic power is 900W, then the mixture is stirred to dry at 63 DEG C, and the medicine is obtained. The medicine has the advantages of being unique in formula, low in price, safe and convenient to use, the effect of the medicine is superior to that of conventionally used western medicines, the medicine can effectively cure the junction and rectal injuries caused during radiotherapy and is high in cure rate, quick in effect and free of toxic and side effects and relapse after curing, simple in preparation process, short in production cycle low in cost and suitable for industrial production and large-scale popularization, and the raw materials are simple and easy to obtain.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating radiation enteritis and its preparation method and application. Background technique [0002] Radiation enteritis is an intestinal complication caused by radiotherapy for malignant tumors in the pelvic cavity, abdominal cavity, and retroperitoneum. The small intestine, colon, and rectum can be involved respectively, so it is also called radiation rectum, colon, and enteritis. Radiation sickness is generally divided into two types: acute and chronic, according to the radiation dose, time, and severity of the intestinal tract. According to the different positions inside and outside the body where the radiation source is placed, it can be divided into external radiation sickness and internal radiation sickness. In the early stage, the renewal of intestinal mucosal cells is inhibited, and later the arteriole wall is swollen and occluded, causing intestinal ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/429A61P1/00A61K31/137A61K31/185A61K31/19
CPCA61K31/429A61K31/137A61K31/185A61K31/19
Inventor 不公告发明人
Owner 郑州莉迪亚医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products